Marshall Wace North America L.P. - SUTRO BIOPHARMA INC ownership

SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 121 filers reported holding SUTRO BIOPHARMA INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Marshall Wace North America L.P. ownership history of SUTRO BIOPHARMA INC
ValueSharesWeighting
Q2 2021$814,000
-79.8%
43,759
-75.3%
0.00%
-82.4%
Q1 2021$4,038,000
-48.1%
177,343
-50.5%
0.02%
-51.4%
Q4 2020$7,773,000357,9890.04%
Other shareholders
SUTRO BIOPHARMA INC shareholders Q3 2021
NameSharesValueWeighting ↓
SV Health Investors, LLC 1,824,542$27,149,00017.55%
Samsara BioCapital, LLC 1,675,579$24,933,0004.84%
AJU IB Investment Co., Ltd. 175,000$2,604,0003.63%
First Light Asset Management, LLC 2,246,588$33,429,0002.39%
Opaleye Management Inc. 680,000$10,118,0002.15%
FRAZIER MANAGEMENT LLC 1,776,479$26,434,0002.04%
Connective Portfolio Management, LLC 35,000$527,0000.93%
Parkman Healthcare Partners LLC 221,219$3,292,0000.73%
SUVRETTA CAPITAL MANAGEMENT, LLC 2,437,795$36,274,0000.70%
Eventide Asset Management 2,708,975$40,310,0000.52%
View complete list of SUTRO BIOPHARMA INC shareholders